Impact of minimal residual disease (MRD) in salvage autologous stem cell transplantation for relapsed myeloma: results from the NCRI Myeloma X (intensive) trial

• de Tute, R.M.
• Cook, G. https://orcid.org/0000-0003-1717-0412
• Cairns, D.A. https://orcid.org/0000-0002-2338-0179
• Brown, J.M.
• Cavenagh, J.
• Ashcroft, A.J.
• Snowden, J.A. https://orcid.org/0000-0001-6819-3476
• Yong, K.
• Tholouli, E.
• Jenner, M.
• Hockaday, A.
• Drayson, M.T.
• Morris, T.C.M.
• Rawstron, A.C.
• Owen, R.G.

© 2024 The Author(s). Except as otherwise noted, this author-accepted version of a journal article published in bone marrow transplantation is made available via the University of Sheffield Research Publications and Copyright Policy under the terms of the Creative Commons Attribution 4.0 International License (CC-BY 4.0), which permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/

• Published: March 2024
• Published (online): 9 January 2024
• Accepted: 27 November 2023
• Submitted: 1 August 2023

• PubMed URL